DividendInvestor.com
First In Dividend Data Worldwide®
DIVIDEND ANNOUNCEMENT: Amgen Inc (NASDAQ:AMGN) on 03/02/2022 declared a dividend of $1.9400 per share
Amgen Inc (NASDAQ:AMGN) on 03/02/2022 declared a dividend of $ 1.9400 per share payable on June 08, 2022 to shareholders of record as of May 17, 2022.
Amgen Inc (NASDAQ:AMGN) has paid dividends since 1997, has a current dividend yield of 3.4456729889% and has increased its dividends for 10 successive years.
Amgen Inc's market cap is $ 125,448,501,090 and has a PE ratio of 21.91. The stock price closed yesterday at $ 225.21 and has a 52 week low/high of $ 198.64 and $ 261.00.
Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).
For more information on Amgen Inc click here.
Dividend Ex Date: May 16, 2022
Dividend Record Date: May 17, 2022
Dividend Payment Date: June 08, 2022
Dividend Amount: $ 1.9400
AMGN LINKS
AMGN Dividend History Detail
AMGN Projected 10 Year Dividend Yield
AMGN Dividend News
AMGN Competitors News
DividendInvestor.com
DividendInvestor.com is a leading worldwide independent provider of dividend information and data for investment professionals. Our mission is to be the First In Dividend Data Worldwide® by designing and developing essential tools and systems for the investment community with the highest level of accuracy and integrity.
Contact:
info@DividendInvestor.com